{"id":71488,"date":"2021-11-17T16:42:01","date_gmt":"2021-11-17T16:42:01","guid":{"rendered":"https:\/\/www.atlasrleye.com\/retinopathie-du-premature\/"},"modified":"2026-02-27T12:07:24","modified_gmt":"2026-02-27T12:07:24","slug":"retinopathie-du-premature","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/fr\/retinopathie-du-premature\/","title":{"rendered":"R\u00c9TINOPATHIE DU PR\u00c9MATUR\u00c9"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=\u00a0\u00bbMALADIES CONG\u00c9NITALES ET P\u00c9DIATRIQUES\u00a0\u00bb font_container=\u00a0\u00bbtag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=\u00a0\u00bbyes\u00a0\u00bb link=\u00a0\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Ffr%2Fatlas%2F%231635506431806-afc59564-1028|\u00a0\u00bb][vc_text_separator title=\u00a0\u00bb\u00a0\u00bb i_icon_fontawesome=\u00a0\u00bbfas fa-eye\u00a0\u00bb i_color=\u00a0\u00bbcustom\u00a0\u00bb i_size=\u00a0\u00bblg\u00a0\u00bb color=\u00a0\u00bbcustom\u00a0\u00bb border_width=\u00a0\u00bb8″ css=\u00a0\u00bb.vc_custom_1637080776101{margin-bottom: -5px !important;}\u00a0\u00bb add_icon=\u00a0\u00bbtrue\u00a0\u00bb accent_color=\u00a0\u00bb#bababa\u00a0\u00bb i_custom_color=\u00a0\u00bb#bababa\u00a0\u00bb][vc_custom_heading source=\u00a0\u00bbpost_title\u00a0\u00bb font_container=\u00a0\u00bbtag:h1|font_size:44px|text_align:center|color:%235f1b52″ use_theme_fonts=\u00a0\u00bbyes\u00a0\u00bb]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column width=\u00a0\u00bb3\/4″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb]<\/p>\n

La r\u00e9tinopathie du pr\u00e9matur\u00e9 (ROP) est une r\u00e9tinopathie isch\u00e9mique des enfants pr\u00e9matur\u00e9s et de faible poids \u00e0 la naissance.<\/p>\n

La n\u00e9ovascularisation de la r\u00e9tine commence \u00e0 la 16\u00e8me semaine de gestation. Elle se d\u00e9veloppe de mani\u00e8re centrifuge \u00e0 partir du disque optique vers l’ora serrata. La r\u00e9tine nasale est vascularis\u00e9e au 8\u00e8me mois de grossesse et la vascularisation de l\u2019ora temporal est g\u00e9n\u00e9ralement termin\u00e9e 1 \u00e0 2 mois plus tard.
Chez le pr\u00e9matur\u00e9 atteint de vascularisation incompl\u00e8te, peut se d\u00e9velopper ROP. Les facteurs de risque qui sont li\u00e9s \u00e0 ROP comprennent la pr\u00e9maturit\u00e9, faible poids \u00e0 la naissance et l\u2019oxyg\u00e9noth\u00e9rapie en soins n\u00e9onatals. <\/p>\n

L\u2019\u00e9tude \u201cEarly treatment for retinopathy of prematurity\u201d a r\u00e9v\u00e9l\u00e9 une pr\u00e9valence de ROP chez les enfants de 1000-1250g de 44%, 751-999g de 76% et < <750g de 93%. Sachant que l’oxyg\u00e9noth\u00e9rapie augmente l’incidence de la ROP, des tentatives ont \u00e9t\u00e9 faites pour r\u00e9duire la concentration d’oxyg\u00e8ne administr\u00e9 aux enfants pr\u00e9matur\u00e9s mais avec un taux de mortalit\u00e9 accru. Avec l’utilisation g\u00e9n\u00e9ralis\u00e9e de l’oxym\u00e9trie de pouls et des syst\u00e8mes qui permettent un meilleur contr\u00f4le de l’oxyg\u00e8ne, l\u2019incidence de la ROP a diminu\u00e9e et la mortalit\u00e9 na pas augment\u00e9. <\/p>\n

Diverses classifications ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour stratifier les patients atteints de ROP. La plus utilis\u00e9 \u00e0 la clinique est la \u00ab Classification International \u00bb. <\/p>\n

Le diagnostic pr\u00e9coce est fondamental. L\u2019examen du fond oculaire est n\u00e9cessaire chez les enfants de 30 semaines ou moins de gestation, avec un poids < <1500 g ou avec un poids \u00e0 la naissance de 1500-2000 g quand soumis \u00e0 l\u2019oxyg\u00e9noth\u00e9rapie. La premi\u00e8re \u00e9valuation doit \u00eatre faite \u00e0 4 semaines de vie ou \u00e0 l\u2019\u00e2ge gestationnel corrig\u00e9e de 30 semaines. <\/p>\n

Le traitement standard reposait presque exclusivement sur la photocoagulation au laser de la r\u00e9tine avasculaire, une m\u00e9thode efficace pour stabiliser la maladie, mais associ\u00e9e \u00e0 une destruction tissulaire et \u00e0 des alt\u00e9rations \u00e0 long terme du champ visuel. L\u2019injection intravitr\u00e9enne d\u2019un volume r\u00e9duit d\u2019anti-VEGF (0,03 ml) chez les pr\u00e9matur\u00e9s a d\u00e9montr\u00e9 une efficacit\u00e9 clinique et une s\u00e9curit\u00e9, \u00e9tablissant une nouvelle approche th\u00e9rapeutique pour la r\u00e9tinopathie du pr\u00e9matur\u00e9. <\/p>\n

 <\/p>\n

\n

R\u00e9f\u00e9rences:<\/p>\n

Travassos A, Teixeira S, Ferreira P, Regadas I, Travassos AS, Esperancinha FE, Prieto I, Pires G, van Velze R, Valido A, Machado Mdo C. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging. 2007 May-Jun;38(3):233-7. doi: 10.3928\/15428877-20070501-09. PMID: 17552391. <\/p>\n<\/div>\n

[\/vc_column_text][\/vc_column][vc_column width=\u00a0\u00bb1\/4″][vc_images_carousel images=\u00a0\u00bb26180,26534,26570,26174″ img_size=\u00a0\u00bbmedium\u00a0\u00bb speed=\u00a0\u00bb2000″ autoplay=\u00a0\u00bbyes\u00a0\u00bb hide_pagination_control=\u00a0\u00bbyes\u00a0\u00bb wrap=\u00a0\u00bbyes\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1748480062967{margin-bottom: 10px !important;}\u00a0\u00bb]

\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>
0<\/div>
Cas Cliniques<\/div><\/div><\/div>[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb.vc_custom_1748469323750{margin-bottom: 10px !important;}\u00a0\u00bb]<\/p>\n

Cas Cliniques<\/span><\/strong><\/h1>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=\u00a0\u00bb1\/4″][vc_column_text css=\u00a0\u00bb.vc_custom_1748469350610{margin-bottom: 0px !important;}\u00a0\u00bb]<\/p>\n

Cas Clinique 1<\/a><\/h4>\n

[\/vc_column_text][vc_gallery type=\u00a0\u00bbimage_grid\u00a0\u00bb images=\u00a0\u00bb26615,26624″ img_size=\u00a0\u00bb150″ css=\u00a0\u00bb.vc_custom_1748469390664{margin-bottom: 10px !important;margin-left: -20px !important;}\u00a0\u00bb][vc_row_inner][vc_column_inner width=\u00a0\u00bb1\/5″ offset=\u00a0\u00bbvc_col-xs-1\/5″]

\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

1<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/5″ offset=\u00a0\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

28<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/5″ offset=\u00a0\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

1<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=\u00a0\u00bb1\/4″][vc_column_text css=\u00a0\u00bb.vc_custom_1748469447262{margin-bottom: 0px !important;}\u00a0\u00bb]<\/p>\n

Cas Clinique 2<\/a><\/h4>\n

[\/vc_column_text][vc_gallery type=\u00a0\u00bbimage_grid\u00a0\u00bb images=\u00a0\u00bb26621,26618″ img_size=\u00a0\u00bb150″ css=\u00a0\u00bb.vc_custom_1748469467706{margin-bottom: 10px !important;margin-left: -20px !important;}\u00a0\u00bb][vc_row_inner][vc_column_inner width=\u00a0\u00bb1\/5″ offset=\u00a0\u00bbvc_col-xs-1\/5″]

\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

16<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/5″ offset=\u00a0\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

132<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/5″ offset=\u00a0\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

0<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=\u00a0\u00bbMALADIES CONG\u00c9NITALES ET P\u00c9DIATRIQUES\u00a0\u00bb font_container=\u00a0\u00bbtag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=\u00a0\u00bbyes\u00a0\u00bb link=\u00a0\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Ffr%2Fatlas%2F%231635506431806-afc59564-1028|\u00a0\u00bb][vc_text_separator title=\u00a0\u00bb\u00a0\u00bb i_icon_fontawesome=\u00a0\u00bbfas fa-eye\u00a0\u00bb i_color=\u00a0\u00bbcustom\u00a0\u00bb i_size=\u00a0\u00bblg\u00a0\u00bb color=\u00a0\u00bbcustom\u00a0\u00bb border_width=\u00a0\u00bb8″ css=\u00a0\u00bb.vc_custom_1637080776101{margin-bottom: -5px !important;}\u00a0\u00bb add_icon=\u00a0\u00bbtrue\u00a0\u00bb accent_color=\u00a0\u00bb#bababa\u00a0\u00bb i_custom_color=\u00a0\u00bb#bababa\u00a0\u00bb][vc_custom_heading source=\u00a0\u00bbpost_title\u00a0\u00bb font_container=\u00a0\u00bbtag:h1|font_size:44px|text_align:center|color:%235f1b52″ use_theme_fonts=\u00a0\u00bbyes\u00a0\u00bb][\/vc_column][\/vc_row][vc_row][vc_column width=\u00a0\u00bb3\/4″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] La r\u00e9tinopathie du pr\u00e9matur\u00e9 (ROP) est une r\u00e9tinopathie isch\u00e9mique des enfants pr\u00e9matur\u00e9s et de […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-71488","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/fr\/wp-json\/wp\/v2\/pages\/71488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/fr\/wp-json\/wp\/v2\/comments?post=71488"}],"version-history":[{"count":23,"href":"https:\/\/www.atlasrleye.com\/fr\/wp-json\/wp\/v2\/pages\/71488\/revisions"}],"predecessor-version":[{"id":121727,"href":"https:\/\/www.atlasrleye.com\/fr\/wp-json\/wp\/v2\/pages\/71488\/revisions\/121727"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/fr\/wp-json\/wp\/v2\/media?parent=71488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}